In silico guided screening of active components of C. lanceolata as 3-chymotrypsin-like protease inhibitors of novel coronavirus.
Researchers conducted computational screening of phytoconstituents from a specific plant to identify potential antiviral hit candidates against 3CLpro, a target for COVID-19 treatment. Stigmasterol showed the highest binding affinity and exhibited stable interactions. This study suggests as a potential drug candidate for further development against the virus.
- Sharma G et al (2023).
- 3 Biotech.
- PubMed:
- 37663751